BackHarvard Bioscience Overview

Harvard Bioscience Current Cash

Harvard Bioscience's current cash is $6.5M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$6.50M
↓ 12.62% YoYΔ $-939000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Harvard Bioscience Current Cash History

Loading

Harvard Bioscience vs. peers: Current Cash Comparison

Loading

Harvard Bioscience Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Harvard Bioscience (HBIO) FAQ

Harvard Bioscience (HBIO) currently reports a current cash of $6.5M as of June 2026. That compares with $7.4M in the prior-year period — down 12.6% year over year. Use the charts on this page to explore Harvard Bioscience's current cash history and peer comparisons.

Harvard Bioscience's current cash decreased from $7.4M to $6.5M — a 12.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Harvard Bioscience reported $6.5M in current cash as of June 2026. That compares with $7.4M in the prior-year period — down 12.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $6.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Harvard Bioscience, and consider following HBIO for alerts when major investors trade the stock.

Harvard Bioscience is classified in the Healthcare sector. On current cash, it currently shows $6.5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HBIO with unrelated industries.